Clinical trial
Role of Inflammation Factors and Insulin Resistance in the Pathophysiology and Treatment Response of Major Depressive Disorder
NCT01699490 is registered in ClinicalTrials.gov with National Cheng-Kung University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Role of Inflammation Factors and Insulin Resistance in the Pathophysiology and Treatment Response of Major Depressive Disorder
- Lead sponsor
- National Cheng-Kung University Hospital
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- August 31, 2012
- Completion date
- July 31, 2015
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.